247 related articles for article (PubMed ID: 25066214)
1. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
3. Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.
Su SF; Huang SM; Han F; Huang Y; Chen CY; Xiao WW; Sun XM; Lu TX
Radiat Oncol; 2013 Jan; 8():17. PubMed ID: 23336282
[TBL] [Abstract][Full Text] [Related]
4. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis.
Dong J; Ng WT; Wong CHL; Li JS; Bollen H; Chow JCH; Eisbruch A; Lee AWM; Lee VHF; Ng SP; Nuyts S; Smee R; Ferlito A
Radiother Oncol; 2024 Jun; 195():110258. PubMed ID: 38537680
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy.
Wang J; Miao Y; Ou X; Wang X; He X; Shen C; Ying H; Hu W; Hu C
Radiat Oncol; 2019 Mar; 14(1):42. PubMed ID: 30866964
[TBL] [Abstract][Full Text] [Related]
7. Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy.
Wu VWC; Tam SY
Radiat Oncol; 2020 May; 15(1):112. PubMed ID: 32414378
[TBL] [Abstract][Full Text] [Related]
8. Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma.
Su SF; Huang Y; Xiao WW; Huang SM; Han F; Xie CM; Lu TX
Radiother Oncol; 2012 Sep; 104(3):312-6. PubMed ID: 22857858
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
Sun Y; Zhou GQ; Qi ZY; Zhang L; Huang SM; Liu LZ; Li L; Lin AH; Ma J
BMC Cancer; 2013 Aug; 13():397. PubMed ID: 23978128
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
[TBL] [Abstract][Full Text] [Related]
11. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
Sun Y; Yu XL; Luo W; Lee AW; Wee JT; Lee N; Zhou GQ; Tang LL; Tao CJ; Guo R; Mao YP; Zhang R; Guo Y; Ma J
Radiother Oncol; 2014 Mar; 110(3):390-7. PubMed ID: 24721546
[TBL] [Abstract][Full Text] [Related]
12. A study of radiation-induced cerebral vascular injury in nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis.
Ye J; Rong X; Xiang Y; Xing Y; Tang Y
PLoS One; 2012; 7(8):e42890. PubMed ID: 22912759
[TBL] [Abstract][Full Text] [Related]
13. Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy.
Mao YP; Zhou GQ; Liu LZ; Guo R; Sun Y; Li L; Lin AH; Zeng MS; Kang TB; Jia WH; Shao JY; Mai HQ; Ma J
Br J Cancer; 2014 May; 110(11):2633-9. PubMed ID: 24809780
[TBL] [Abstract][Full Text] [Related]
14. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
Kong C; Zhu XZ; Lee TF; Feng PB; Xu JH; Qian PD; Zhang LF; He X; Huang SF; Zhang YQ
Sci Rep; 2016 May; 6():26378. PubMed ID: 27210263
[TBL] [Abstract][Full Text] [Related]
15. Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.
Liu S; Lu T; Zhao C; Shen J; Tian Y; Guan Y; Zeng L; Xiao W; Huang S; Han F
J Neurooncol; 2014 Sep; 119(2):421-8. PubMed ID: 24986091
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J
BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030
[TBL] [Abstract][Full Text] [Related]
17. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
[TBL] [Abstract][Full Text] [Related]
18. Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Zeng L; Huang SM; Tian YM; Sun XM; Han F; Lu TX; Deng XW
Radiology; 2015 Jul; 276(1):243-9. PubMed ID: 25658039
[TBL] [Abstract][Full Text] [Related]
19. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
[TBL] [Abstract][Full Text] [Related]
20. Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China.
Wen DW; Lin L; Mao YP; Chen CY; Chen FP; Wu CF; Huang XD; Li ZX; Xu SS; Kou J; Yang XL; Ma J; Sun Y; Zhou GQ
Radiother Oncol; 2021 Apr; 157():99-105. PubMed ID: 33484752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
